Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Histamine H3receptor antagonists in relation to epilepsy and neurodegeneration: a systemic consideration of recent progress and perspectives
Malay Bhowmik, Razia Khanam, Divya Vohora
British Journal of Pharmacology (2012) Vol. 167, Iss. 7, pp. 1398-1414
Open Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the Last Decade
Masha G. Savelieff, Geewoo Nam, Juhye Kang, et al.
Chemical Reviews (2018) Vol. 119, Iss. 2, pp. 1221-1322
Closed Access | Times Cited: 479
Histamine H3 receptor as a potential target for cognitive symptoms in neuropsychiatric diseases
Bassem Sadek, Ali Saad, Adel Sadeq, et al.
Behavioural Brain Research (2016) Vol. 312, pp. 415-430
Closed Access | Times Cited: 144
Histamine, histamine receptors, and neuropathic pain relief
Ilona Obara, Vsevolod Telezhkin, Ibrahim Alrashdi, et al.
British Journal of Pharmacology (2019) Vol. 177, Iss. 3, pp. 580-599
Open Access | Times Cited: 126
Mechanistic Insights of Chelator Complexes with Essential Transition Metals: Antioxidant/Pro-Oxidant Activity and Applications in Medicine
Viktor A. Timoshnikov, Olga Yu. Selyutina, Nikolay E. Polyakov, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1247-1247
Open Access | Times Cited: 52
Targeting Microglia in Neuroinflammation: H3 Receptor Antagonists as a Novel Therapeutic Approach for Alzheimer’s Disease, Parkinson’s Disease, and Autism Spectrum Disorder
Shilu Deepa Thomas, Sabna Abdalla, Nermin Eissa, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 831-831
Open Access | Times Cited: 9
Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs
Dubravka Švob Štrac, Nela Pivac, Ilse Smolders, et al.
Frontiers in Neuroscience (2016) Vol. 10
Open Access | Times Cited: 83
Anxiolytic and antidepressant-like activities of the novel and potent non-imidazole histamine H3 receptor antagonist ST-1283
Bassem Sadek, Amine Bahí, Johannes Stephan Schwed, et al.
Drug Design Development and Therapy (2014), pp. 627-627
Open Access | Times Cited: 77
Cherry-picked ligands at histamine receptor subtypes
Bassem Sadek, Holger Stark
Neuropharmacology (2015) Vol. 106, pp. 56-73
Closed Access | Times Cited: 73
Histamine H3 receptors aggravate cerebral ischaemic injury by histamine-independent mechanisms
Haijing Yan, Xiangnan Zhang, Weiwei Hu, et al.
Nature Communications (2014) Vol. 5, Iss. 1
Open Access | Times Cited: 68
Histamine H3 receptor antagonists/inverse agonists: Where do they go?
Nakisa Ghamari, Omid Zarei, José‐Antonio Arias‐Montaño, et al.
Pharmacology & Therapeutics (2019) Vol. 200, pp. 69-84
Closed Access | Times Cited: 60
The dual-active histamine H3 receptor antagonist and acetylcholine esterase inhibitor E100 ameliorates stereotyped repetitive behavior and neuroinflammmation in sodium valproate induced autism in mice
Nermin Eissa, Sheikh Azimullah, Petrilla Jayaprakash, et al.
Chemico-Biological Interactions (2019) Vol. 312, pp. 108775-108775
Closed Access | Times Cited: 55
Efficacy of the histamine 3 receptor (H3R) antagonist pitolisant (formerly known as tiprolisant; BF2.649) in epilepsy: Dose-dependent effects in the human photosensitivity model
Dorothée Kasteleijn- Nolst Trenité, D. Parain, Pierre Genton, et al.
Epilepsy & Behavior (2013) Vol. 28, Iss. 1, pp. 66-70
Closed Access | Times Cited: 70
Anticonvulsant and procognitive properties of the non-imidazole histamine H3 receptor antagonist DL77 in male adult rats
Bassem Sadek, Ali Saad, Subramanian Dhanasekaran, et al.
Neuropharmacology (2015) Vol. 106, pp. 46-55
Closed Access | Times Cited: 63
Novel 1-Phenyl-3-hydroxy-4-pyridinone Derivatives as Multifunctional Agents for the Therapy of Alzheimer’s Disease
Rong Sheng, Li Tang, Jiang Liu, et al.
ACS Chemical Neuroscience (2015) Vol. 7, Iss. 1, pp. 69-81
Closed Access | Times Cited: 57
Role of the Histamine H3 Receptor in the Central Nervous System
Eberhard Schlicker, M. Kathmann
Handbook of experimental pharmacology (2016), pp. 277-299
Closed Access | Times Cited: 54
G protein-coupled receptors in acquired epilepsy: Druggability and translatability
Ying Yu, Davis T. Nguyen, Jianxiong Jiang
Progress in Neurobiology (2019) Vol. 183, pp. 101682-101682
Open Access | Times Cited: 52
Multiple Targeting Approaches on Histamine H3 Receptor Antagonists
Mohammad A. Khanfar, Anna Affini, Kiril Lutsenko, et al.
Frontiers in Neuroscience (2016) Vol. 10
Open Access | Times Cited: 47
The Dual-Active Histamine H3 Receptor Antagonist and Acetylcholine Esterase Inhibitor E100 Alleviates Autistic-Like Behaviors and Oxidative Stress in Valproic Acid Induced Autism in Mice
Nermin Eissa, Sheikh Azimullah, Petrilla Jayaprakash, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3996-3996
Open Access | Times Cited: 39
The chronological evolution of fluorescent GPCR probes for bioimaging
Yingxu Wu, Boyu Zhang, Hu Xu, et al.
Coordination Chemistry Reviews (2023) Vol. 480, pp. 215040-215040
Closed Access | Times Cited: 13
Histaminergic system in brain disorders: lessons from the translational approach and future perspectives
Diego Baronio, Taylor Gonchoroski, Kamila Castro, et al.
Annals of General Psychiatry (2014) Vol. 13, Iss. 1
Open Access | Times Cited: 49
The histamine H3-receptor inverse agonist Pitolisant improves fear memory in mice
Christian Brabant, Yana Charlier, Ezio Tirelli
Behavioural Brain Research (2013) Vol. 243, pp. 199-204
Open Access | Times Cited: 41
The dual-acting H3 receptor antagonist and AChE inhibitor UW-MD-71 dose-dependently enhances memory retrieval and reverses dizocilpine-induced memory impairment in rats
Nadia Khan, Ali Saad, Syed M. Nurulain, et al.
Behavioural Brain Research (2015) Vol. 297, pp. 155-164
Closed Access | Times Cited: 40
Inhibition of histamine receptor 3 suppresses glioblastoma tumor growth, invasion, and epithelial-to-mesenchymal transition
Jiaji Lin, Tianzhi Zhao, Wen-Ke Cai, et al.
Oncotarget (2015) Vol. 6, Iss. 19, pp. 17107-17120
Open Access | Times Cited: 38
The dual-acting AChE inhibitor and H3 receptor antagonist UW-MD-72 reverses amnesia induced by scopolamine or dizocilpine in passive avoidance paradigm in rats
Bassem Sadek, Nadia Khan, Fouad H. Darras, et al.
Physiology & Behavior (2016) Vol. 165, pp. 383-391
Closed Access | Times Cited: 38
Histamine Regulates the Inflammatory Profile of SOD1-G93A Microglia and the Histaminergic System Is Dysregulated in Amyotrophic Lateral Sclerosis
Savina Apolloni, Paola Fabbrizio, Susanna Amadio, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top